Valuation: Enovis Corporation

Market Cap 1.08B 962M 896M 815M 1.54B 104B 1.55B 10.82B 4.21B 52.98B 4.05B 3.96B 170B P/E 2026 *
92.5x
P/E 2027 * 23.9x
Enterprise Value 2.38B 2.13B 1.98B 1.8B 3.4B 230B 3.42B 23.94B 9.32B 117B 8.95B 8.76B 377B EV / Sales 2026 *
1.02x
EV / Sales 2027 * 0.95x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day+0.13%
1 week+2.92%
Current month+2.30%
1 month+0.70%
3 months-16.93%
6 months-17.45%
Current year-29.84%
1 week 17.56
Extreme 17.56
18.96
1 month 17.3
Extreme 17.3
20.22
Current year 17.3
Extreme 17.3
31.66
1 year 17.3
Extreme 17.3
34.28
3 years 17.3
Extreme 17.3
65.03
5 years 17.3
Extreme 17.3
164.01
10 years 17.3
Extreme 17.3
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

958 0.0017%
04/09/26 Buy

Chief Administrative Officer

2,660 0.0047%
04/09/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%+2.92%-41.63%-62.91% 1.08B
+0.69%-0.87%-25.63%+4.05% 173B
-0.08%-1.71%-9.96%+15.52% 113B
-0.68%+3.60%-23.02%+7.71% 109B
+0.62%+0.55%-47.34%-11.37% 74.44B
-0.24%+3.66%+4.02%+70.20% 60.1B
+3.27%+8.93%+12.12%+69.34% 51.87B
+3.18%-1.72%-6.68%-30.79% 49.21B
+0.45%-0.38%-16.50%+22.43% 41.52B
-1.29%+0.25%+29.60%+3.45% 32.79B
Average +0.66%+0.85%-12.50%+8.76% 70.62B
Weighted average by Cap. +0.60%+0.42%-15.32%+13.77%

Financials

2026 *2027 *
Net sales 2.34B 2.09B 1.94B 1.77B 3.33B 225B 3.36B 23.49B 9.14B 115B 8.78B 8.59B 370B 2.45B 2.19B 2.04B 1.86B 3.49B 236B 3.52B 24.64B 9.59B 121B 9.21B 9.01B 388B
Net income 11.32M 10.1M 9.41M 8.57M 16.13M 1.09B 16.25M 114M 44.25M 557M 42.51M 41.6M 1.79B 39M 34.79M 32.41M 29.5M 55.55M 3.76B 55.96M 392M 152M 1.92B 146M 143M 6.16B
Net Debt 1.31B 1.17B 1.09B 988M 1.86B 126B 1.87B 13.12B 5.1B 64.21B 4.9B 4.8B 206B 1.25B 1.11B 1.03B 942M 1.77B 120B 1.79B 12.5B 4.87B 61.2B 4.67B 4.57B 197B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
05/10/26 US$18.69 +5.18% 1,364,630
02/10/26 US$17.77 -1.55% 1,366,896
01/10/26 US$18.05 -1.20% 1,592,109
30/09/26 US$18.27 -1.03% 1,942,984
29/09/26 US$18.46 +1.65% 1,530,900
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.69USD
Average target price
37.58USD
Spread / Average Target
+101.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock